Stay up-to- date with news from the CMSC Meeting in June 2016
Couldn’t make it to the congress? We are very happy to provide you with meeting coverage from the 2016 Annual Meeting of the CMSC, which is the largest North American meeting on MS with typically over 2000 delegates in attendance:
Please watch the newest interviews with leading MS experts, recorded at CMSC 2016:
Dr. Jerry Wolinsky: Highlights of the John Whitaker Memorial lecture
Read conference reports on:
- Real-World Assessment of Disease-Modifying Drugs (poster presentation by Chris Kozma)
- The Influence of Lifestyle Factors on MS (presentation by Allen Bowling)
- The Importance of Lipids in MS (presentation by John Nieland)
- Use of MRI as a Monitoring Tool (presentation by Gavin Giovannoni)
- Updates in Disease Management (presentation by Annette Okai)
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis
Karlyn A. Edwards, Ivan R. Molton, Amanda E. Smith, Dawn M. Ehde, Charles H. Bombardier, Samuel Battalio, Mark P. JensenArchives of Physical Medicine and Rehabilitation, Available online 23 March 2016
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration
Sofia Anastasiadou, Bernd KnöllExperimental Neurology, Volume 279, May 2016, Pages 243–260
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Elena H Martinez-Lapiscina, Sam Arnow, James A Wilson, Shiv Saidha, Jana Lizrova Preiningerova, et al.The Lancet Neurology, Volume 15, Issue 6, May 2016, Pages 574–584
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial
Samuel F. Hunter, Mark Agius, Deborah M. Miller, Gary Cutter, Luigi Barbato, Kevin McCague, Xiangyi Meng, Neetu Agashivala, Peter Chin, Eric Hollander
Journal of the Neurological Sciences, June 2016, Pages 190 - 198
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life – A post hoc analysis of the TEMSO and TOWER studies
Mathias Mäurer, Giancarlo Comi, Mark S. Freedman, Ludwig Kappos, Tomas P. Olsson, Jerry S. Wolinsky, Aaron E. Miller, Catherine Dive-Pouletty, Sylvie Bozzi, Paul W. O’Connor
Multiple Sclerosis and Related Disorders, Volume 7, May 2016, Pages 33–40
About the Editors
- Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
- Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...
- Rebecca Farber, MD is a Multiple Sclerosis fellow at The Corinne Goldsmith Dickinson Center for MS at Mount Sinai Hospital,...
- Aug 201618Aug 201621
Advanced Education in Neurology in Asian Oceanian RegionKuala Lumpur, MalaysiaKuala Lumpur, MalaysiaThe Asian and Oceanian Congress of Neurology (AOCN), which is organized by the Malaysian Society of Neurosciences, is renowned for...
- Aug 201621Aug 201628Fort Lauderdale, Florida, USAThis 7-night Caribbean cruise conference is a round-trip starting from Fort Lauderdale. The conference sessions generally take place on days...Fort Lauderdale, United States
- Sep 20169Sep 201610
Sensory contributions to gait and balance in MSPortland, United StatesPortland, United StatesThis symposium is intended for physicians (neurologists, physiatrists), physical therapists, occupational therapists, rehabilitation scientists, nurses, and physician assistants working in...